Leveraged Commentary and Data’s (LCD) credit data, news, and research are now on PitchBook.
Learn more »
INHIBITOR Therapeutics Overview
(As of Friday Closing)
INHIBITOR Therapeutics General Information
Inhibitor Therapeutics Inc is a pharmaceutical development company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders. The company's main focus is to advance its lead product, SUBA-Itraconazole a patented, oral formulation of the currently marketed, well-understood, anti-fungal drug, Itraconazole, for prostate and lung cancer.